Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Expression of Yo Antigen in a Prostatic Adenocarcinoma.
Rosine N, Chrétien P, Adam C, Beaudonnet G, Not A, Drai J, Vahedi K, Cauquil C, Theaudin M. Rosine N, et al. Among authors: beaudonnet g. Can J Neurol Sci. 2017 Mar;44(2):221-223. doi: 10.1017/cjn.2016.400. Can J Neurol Sci. 2017. PMID: 28231864 No abstract available.
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study.
Adams D, Polydefkis M, González-Duarte A, Wixner J, Kristen AV, Schmidt HH, Berk JL, Losada López IA, Dispenzieri A, Quan D, Conceição IM, Slama MS, Gillmore JD, Kyriakides T, Ajroud-Driss S, Waddington-Cruz M, Mezei MM, Planté-Bordeneuve V, Attarian S, Mauricio E, Brannagan TH 3rd, Ueda M, Aldinc E, Wang JJ, White MT, Vest J, Berber E, Sweetser MT, Coelho T; patisiran Global OLE study group. Adams D, et al. Lancet Neurol. 2021 Jan;20(1):49-59. doi: 10.1016/S1474-4422(20)30368-9. Epub 2020 Nov 16. Lancet Neurol. 2021. PMID: 33212063 Clinical Trial.
Inflammatory demyelinating polyneuropathies and lymphoma: clues to diagnosis and therapy.
Noel N, Beaudonnet G, Cauquil C, Laurenge A, De Menthon M, Labeyrie C, Chrétien P, Adam C, Hacein-Bey-Abina S, Goujard C, Lambotte O, Adams D. Noel N, et al. Among authors: beaudonnet g. Leuk Lymphoma. 2021 Aug;62(8):2000-2004. doi: 10.1080/10428194.2021.1889535. Epub 2021 Feb 24. Leuk Lymphoma. 2021. PMID: 33627032 No abstract available.
Neurological complications induced by immune checkpoint inhibitors: a comprehensive descriptive case-series unravelling high risk of long-term sequelae.
Plaçais L, Michot JM, Champiat S, Romano-Martin P, Baldini C, Joao MS, Marabelle A, Voisin AL, Not A, Labeyrie C, Beaudonnet G, Laparra A, Maria ATJ, Masseau A, Dehette S, Deleporte A, Echaniz-Laguna A, Denier C, Adams D, Lambotte O, Noel N, Cauquil C. Plaçais L, et al. Among authors: beaudonnet g. Brain Commun. 2021 Oct 1;3(4):fcab220. doi: 10.1093/braincomms/fcab220. eCollection 2021. Brain Commun. 2021. PMID: 34651126 Free PMC article.
Efficacy and safety of vutrisiran for patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: a randomized clinical trial.
Adams D, Tournev IL, Taylor MS, Coelho T, Planté-Bordeneuve V, Berk JL, González-Duarte A, Gillmore JD, Low SC, Sekijima Y, Obici L, Chen C, Badri P, Arum SM, Vest J, Polydefkis M; HELIOS-A Collaborators. Adams D, et al. Amyloid. 2023 Mar;30(1):1-9. doi: 10.1080/13506129.2022.2091985. Epub 2022 Jul 23. Amyloid. 2023. PMID: 35875890 Clinical Trial.
22 results